News
Initiation of SSRI or SNRI was confirmed by more than one filled prescription of either brand or generic drug names ... and/or pulmonary embolism and had been on heparin, warfarin, apixaban, ...
Warfarin has many drug-drug interactions, so it’s possible that [more patients with] severe cancer are being prescribed apixaban and rivaroxaban, and that’s why we’re seeing that reverse causality.” ...
Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...
Sandoz's Erelzi has become the first biosimilar of Amgen's Enbrel (etanercept) blockbuster inflammatory diseases drug to gain FDA approval. Erelzi (etanercept-szzs) has been approved in all uses ...
chief executive of Switzerland’s Sandoz, said he backed the intention of the administration’s “most favoured nation” policy — where it is seeking to cut prescription drug prices to the ...
public comments and talks with drug companies before Medicare implemented discounts. The Biden administration lowered prices on 10 widely prescribed drugs, such as the blood thinner Eliquis ...
By Jan Hoffman President Trump has long railed against drug traffickers. He has said they should be given the death penalty “for their heinous acts.” On the first day of his second term ...
Lev Facher covers the U.S. addiction and overdose crisis. Drug deaths plummeted in 2024, according to new federal data. An estimated 80,391 people died of a drug overdose in the U.S. last year ...
Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US ...
President Trump directed his administration to craft a policy that ties U.S. drug prices to what other countries pay. Photo: Andrew Harnik/Getty Images It is appropriate that Donald Trump chose to ...
Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results